spacer
home > epc > summer 2002 > change management through the looking glass
PUBLICATIONS
European Pharmaceutical Contractor

Change Management Through the Looking Glass

Beyond the world of comfortable consistency lies a wonderland of chaotic uncertainty - the domain of change. The journey down the rabbit hole to the unknown often begins as a peek into tiny management and process doorways through which we want to squeeze painlessly into a beautiful garden of transformation. Change is never easy. Lewis Carroll's Alice in Wonderland began navigating change by questioning her very name and then swimming in a pool of her own tears. Dealing with change is no less demanding in the pharmaceutical industry. Competitive stakes are high and getting higher. The first company to market with a blockbuster drug can enjoy a virtual monopoly for years and possibly transform the lives of millions of people. Accepting the inevitability of change is a start. However, it is those who harness and manage the power of change that can sustain the momentum of competitive advantage.

Change and adaptation within the clinical trial process - particularly through effective automation - can make a tremendous difference to business throughput. Over time, the clinical trial process has evolved into an administrative hierarchy. People with years of experience in this context implement various common methodologies accepted for their apparent reliability. But the pressure of competition has no respect for hierarchy. Commonly accepted practices are rarely an adequate basis for breakthrough competitive results. Many of the delays in the drug development process are largely a consequence of slow adaptation to the pressures of competitive change.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Philip Holt, Vice President of Life Sciences at Integic Corporation

Philip Holt is Vice President of Life Sciences at Integic Corporation. He has worked extensively over the past two decades in the development of technology strategies and methodologies oriented toward repeatable results.

Philip has also held management and executive positions at Baxter, Oacis Healthcare Systems and SAIC, as well as founding Altis, an international consultancy.

spacer
Philip Holt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Surge of Indian biosimilars market forecast in 2019

16th April 2019: New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India specific findings from CPhI’s bio league tables predict strong ‘bio growth potential’ in India throughout 2019 in the build-up to the 13th edition of CPhI India 2019, which will take place at the India Expo Centre in Delhi NCR.
More info >>

White Papers

Key to Outsourcing Method Development and Validation: A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation. As companies are focussing on achieving ever shorter times of drug to market, it is vital that a tailored, pragmatic approach is adopted when engaging in both method development and validation activities for an Active Pharmaceutical Ingredient (API) or drug product (DP). Although methods still require a high degree of robustness, the overall strategy should encompass a full evaluation of the regulatory requirements applicable to the particular phase of the drug life-cycle; this is pivotal in Key to Outsourcing Method Development and Validation A Pragmatic Approach order to ensure a successful regulatory submission, where the applicant must demonstrate suitable validation of all methods used to support the filing.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement